GlassScriptPhysician profile
Alan Mark Nieder
NPI 1578503538
$45,020.96
in general payments reported to CMS, 2019-2025
55 companies · $1,629 in 2025
The $1,629 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,993 · 2020: $696 · 2021: $21K · 2022: $12K · 2023: $7,395 · 2024: $877 · 2025: $1,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,465 · Honoraria: $4,200 · Travel and Lodging: $231 · Education: $5.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,464.68 |
| Honoraria | $4,200.00 |
| Travel and Lodging | $230.95 |
| Education | $5.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $35,121.78 | 2020-2025 | Jelmyto |
| Boston Scientific Corporation | $1,131.25 | 2019-2025 | Spaceoar Vue System - 10ml, Rezum Generator, Lithovue |
| Coloplast Corp | $940.26 | 2019-2025 | Titan, Self-Cath, Speedicath |
| Astellas Pharma US INC | $550.40 | 2019-2024 | Xtandi, Myrbetriq |
| Laborie Medical Technologies Corp. | $526.20 | 2022-2025 | |
| Pfizer INC. | $519.89 | 2020-2025 | |
| Sumitomo Pharma America, INC. | $497.97 | 2023-2025 | Orgovyx, Gemtesa |
| Blue Earth Diagnostics | $455.40 | 2021-2024 | |
| Abbvie INC. | $370.33 | 2019-2025 | |
| Myriad Genetic Laboratories, INC. | $353.63 | 2021-2023 | Prolaris, Myrisk |
| Janssen Biotech, INC. | $352.01 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Photocure INC | $339.28 | 2019-2023 | Cysview |
| Myovant Sciences INC. | $286.40 | 2021-2022 | |
| Edap Technomed INC | $283.46 | 2023 | |
| Ferring Pharmaceuticals INC. | $274.33 | 2019-2025 | Adstiladrin |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $242.07 | 2023-2025 | |
| Neotract INC. | $220.37 | 2019 | |
| 180 Medical, INC. | $203.40 | 2019-2025 | Gentlecath |
| Tolmar Pharmaceuticals, INC. | $167.50 | 2019-2022 | |
| Ambu INC. | $159.49 | 2020-2025 | |
| Cook Medical LLC | $157.82 | 2021-2025 | Litho 150, Cook |
| Immunitybio, INC. | $146.31 | 2025 | |
| Axonics, INC. | $142.46 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $140.74 | 2020-2023 | Keytruda, Lynparza |
| Convatec INC. | $117.50 | 2022 | |
| Teleflex LLC | $114.14 | 2022-2025 | Deknatel, Urolift |
| Procept Biorobotics Corporation | $111.81 | 2022 | |
| Comsort, INC | $100.00 | 2019 | |
| Olympus America INC. | $91.92 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $84.66 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $82.21 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.40 | 2021-2025 | |
| Verity Pharmaceuticals INC. | $62.05 | 2024-2025 | Trelstar, Tlando |
| C. R. Bard, INC. & Subsidiaries | $57.26 | 2022-2025 | Bard Urinary Drainage Bag |
| Davol INC. | $53.17 | 2019-2020 | |
| Covidien LP | $43.47 | 2019 | |
| Philips North America LLC | $42.02 | 2024-2025 | Oncology Solution, (8584) Uronav, Uronav |
| Metuchen Pharmaceuticals | $39.96 | 2019 | |
| Foundation Medicine, INC. | $38.27 | 2019-2022 | |
| Tolmar, INC. | $36.64 | 2023-2024 | |
| Amgen INC. | $32.26 | 2019-2020 | |
| Travere Therapeutics, INC. | $32.05 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $25.24 | 2025 | Provenge |
| Astrazeneca Pharmaceuticals LP | $24.65 | 2021 | |
| Progenics Pharmaceuticals, INC. | $24.19 | 2022 | |
| Genentech USA, INC. | $19.08 | 2019 | |
| Medtronic USA, INC. | $18.61 | 2019 | |
| Kyowa Kirin, INC. | $17.95 | 2020 | |
| Telix Pharmaceuticals | $16.98 | 2023 | Illuccix |
| Angiodynamics, INC. | $16.60 | 2025 | Nanoknife |
| Blueprint Medicines Corporation | $15.66 | 2025 | Ayvakit |
| Clarus Therapeutics INC. | $15.49 | 2021 | |
| Allergan, INC. | $15.45 | 2019 | |
| Daiichi Sankyo INC. | $11.98 | 2020 | |
| Janssen Pharmaceuticals, INC | $8.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Nieder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.